Loading...
Loading...
MDT| Name | Value |
|---|---|
| Revenues | 7,702.0M |
| Cost of Revenue | 2,628.0M |
| Gross Profit | 5,074.0M |
| Operating Expense | 3,711.0M |
| Operating I/L | 1,268.0M |
| Other Income/Expense | -18.0M |
| Interest Income | 111.0M |
| Pretax | 1,196.0M |
| Income Tax Expense | 400.0M |
| Net Income/Loss | 791.0M |
Medtronic plc is a global leader in developing, manufacturing, and selling device-based medical therapies. The company's Cardiovascular Portfolio includes implantable cardiac devices, ablation products, and remote monitoring software. Its Medical Surgical Portfolio offers surgical stapling devices, wound closure products, and minimally invasive gastrointestinal diagnostics. The Neuroscience Portfolio provides products for spinal and neurosurgery, as well as image-guided surgery systems. The Diabetes Operating Unit segment offers insulin pumps, continuous glucose monitoring systems, and smart insulin pen systems. Medtronic generates revenue by selling a wide range of medical devices and therapies to healthcare systems, physicians, clinicians, and patients worldwide.
